Minze Health
Enabling urologists to diagnose and monitor patients with voiding disorders at home, in the hospital or private practice.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
* | €4.8m | Early VC | |
| Total Funding | 000k | ||
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Minze Health is a digital health company founded in 2015 by Jiri Vermeulen, Gilles Tas, and Josef Sageder in Antwerp, Belgium. The founders created the company to provide a home-based solution to guide patients with Lower Urinary Tract Symptoms (LUTS) through the entire care pathway, addressing the underuse and unreliability of traditional diagnostic procedures. The company specializes in digital health solutions for urology, focusing on remote patient monitoring and data collection to transform the diagnosis and treatment of urinary conditions.
The company develops a range of products including digital diagnostics, remote patient monitoring systems, and Prescription Digital Therapeutics (PDTs). Its product suite includes 'Homeflow', a home-use uroflowmetry system; 'Hospiflow', for in-clinic use; and the 'Diary Pod', an automated bladder diary. These interconnected devices work with a mobile app and a cloud-based clinician portal to provide continuous, real-world data, enabling healthcare professionals to make faster, more accurate diagnoses and create personalized treatment plans. Minze also offers 13-week personalized digital therapy programs for conditions like male LUTS and overactive bladder (OAB), which integrate lifestyle coaching and pelvic floor training.
Minze Health operates on a B2B model, selling its CE-marked and FDA-cleared products to hospitals, urology clinics, and physical therapists. Its solutions are used by over 160,000 patients in more than 20 countries. The company generates revenue by selling its hardware and software and is expanding into the US market, leveraging new reimbursement codes for home uroflowmetry. Minze has raised a total of $9.46 million over several funding rounds from investors including White Fund, Capricorn Partners, and PMV, to support international expansion and the development of its PDTs for markets like Germany and France.
Keywords: digital health, urology, remote patient monitoring, LUTS, uroflowmetry, medical devices, digital therapeutics, bladder diary, continence care, MedTech